sclerosis

(redirected from lateral sclerosis)
Also found in: Dictionary, Medical, Encyclopedia.
Graphic Thesaurus  🔍
Display ON
Animation ON
Legend
Synonym
Antonym
Related
  • noun

Synonyms for sclerosis

References in periodicals archive ?
Association between dietary intake and function in amyotrophic lateral sclerosis.
The report reviews key players involved in the therapeutics development for Amyotrophic Lateral Sclerosis and enlists all their major and minor projects
A snapshot of the global therapeutic scenario for Amyotrophic Lateral Sclerosis.
This class of compounds has been the most commercially successful in the past decade, particularly in the multiple sclerosis market, with many clinical trials underway for amyotrophic lateral sclerosis.
Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, is a progressive neurodegenerative disease that affects nerve cells in the brain and the spinal cord.
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder caused by selective loss of motor neurons in the spinal cord, brainstem, and motor cortex, which is characterized by progressive wasting and weaknesses of the limb, bulbar, and respiratory muscles.
Global Markets Direct's, 'Amyotrophic Lateral Sclerosis - Pipeline Review, H2 2011', provides an overview of the Amyotrophic Lateral Sclerosis therapeutic pipeline.
M2 EQUITYBITES-October 12, 2016-MediciNova awarded US FDA's orphan drug designation for MN-166 (ibudilast) for treating Amyotrophic Lateral Sclerosis
Los Angeles County Sheriff Lee Baca joined the crowd in front of the Santa Clarita City Hall, supporting former city employee Mike Johnson and local Sheriff's Deputy Andy Vaughan - both men in their 30s who are afflicted with amyotrophic lateral sclerosis, also known as Lou Gehrig's disease.
com/research/16d5db/amyotrophic_latera) has announced the addition of GlobalData 's new report "Amyotrophic Lateral Sclerosis (ALS) Therapeutics - Pipeline Assessment and Market Forecasts to 2018" to their offering.
M2 EQUITYBITES-March 31, 2016-Herantis Pharma receives EMA's positive opinion for application of orphan drug designation for amyotrophic lateral sclerosis drug
M2 PHARMA-March 31, 2016-Herantis Pharma receives EMA's positive opinion for application of orphan drug designation for amyotrophic lateral sclerosis drug
Today, physicians diagnose people with amyotrophic lateral sclerosis (ALS)--better known as Lou Gehrig's disease--by process of elimination.
Johnson, a 36-year-old former Santa Clarita employee and single father was diagnosed with Amyotrophic Lateral Sclerosis (ALS), commonly known as Lou Gehrig's Disease, in 1997.
com/research/9e8a7f/amyotrophic_latera) has announced the addition of GlobalData's new report "Amyotrophic Lateral Sclerosis Global Clinical Trials Review, Q1, 2011" to their offering.